STOCK TITAN

Ethos (Nasdaq: LIFE) grows 2025 revenue and profit with 65% Q4 surge

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Ethos Technologies Inc. reported strong fourth quarter and full-year 2025 results, highlighted by rapid growth and rising profitability. Q4 revenue increased to $110,077 thousand from $66,524 thousand a year earlier, which the company described as 65% year-over-year revenue growth. Net income for the quarter rose to $24,561 thousand from $9,548 thousand.

For full-year 2025, revenue grew to $387,608 thousand from $254,926 thousand, while net income increased to $71,151 thousand from $48,832 thousand. Adjusted EBITDA reached $89,038 thousand with an Adjusted EBITDA Margin of 23%, and Contribution Profit was $162,035 thousand with a Contribution Margin of 42%.

Ethos highlighted reaching 500,000 activated policies and emphasized its technology platform and mission to democratize access to life insurance. The company also provided a financial outlook for the first quarter and full fiscal year 2026 and hosted an investor conference call to discuss these results and expectations.

Positive

  • Strong 2025 revenue and earnings growth: Revenue increased from $254,926 thousand to $387,608 thousand and net income rose from $48,832 thousand to $71,151 thousand, with Q4 revenue up 65% year over year to $110,077 thousand.
  • Improving profitability metrics at scale: 2025 Adjusted EBITDA reached $89,038 thousand with a 23% Adjusted EBITDA Margin, and Contribution Profit was $162,035 thousand with a 42% Contribution Margin, indicating attractive unit economics as the business grows.

Negative

  • None.

Insights

Ethos combined fast revenue growth with rising profitability in 2025.

Ethos Technologies delivered notable operating leverage in 2025. Revenue expanded from $254,926 thousand to $387,608 thousand, while net income rose from $48,832 thousand to $71,151 thousand. This indicates the business scaled without a proportional increase in total costs and expenses.

Non-GAAP metrics reinforce this picture. Adjusted EBITDA increased to $89,038 thousand with a stable 23% margin, and Contribution Profit climbed to $162,035 thousand with a 42% Contribution Margin. These measures suggest the core economics of Ethos’ distribution and policy base are strengthening as volumes grow.

On the balance sheet, cash and cash equivalents rose to $91,091 thousand, and total assets reached $515,337 thousand. Investors may focus on how Ethos’ 2026 outlook, referenced in the release, aligns with this trajectory and whether margins remain resilient as the company continues investing in sales, marketing and technology.

false 0001788451 0001788451 2026-02-25 2026-02-25
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 25, 2026

 

 

ETHOS TECHNOLOGIES INC.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-43065   81-3181024

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

90 New Montgomery Street, Suite 1500

San Francisco, CA

    94105
(Address of Principal Executive Offices)     (Zip Code)

(415) 915-0665

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Class A Common Stock, $0.0001 par value   LIFE   Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

 

 
 


Item 2.02

Results of Operations and Financial Condition.

On February 25, 2026, Ethos Technologies Inc. issued a press release announcing financial results for the fiscal quarter and year ended December 31, 2025. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in this Item 2.02 of this Current Report on Form 8-K (including the accompanying Exhibit 99.1 hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filings, except as expressly incorporated by specific reference in such a filing.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit
No.

  

Description

99.1    Press Release dated February 25, 2026.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Ethos Technologies Inc.
Dated: February 25, 2026  
    By:  

/s/ Christopher Capozzi

      Christopher Capozzi
      Chief Financial Officer

Exhibit 99.1

Ethos Reports Fourth Quarter and Fiscal Year 2025 Financial Results

 

 

Records full-year revenue of $387.6 million, growing 52% year-over-year

 

 

Achieves Net Income of $24.6 million and Adjusted EBITDA of $25.8 million in Q4, reflecting a 22% margin and a 23% Adjusted EBITDA margin

 

 

Delivers third consecutive year of revenue growth greater than 50%

Austin, TX — February 25, 2026 — Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2025.

“We delivered a strong close to 2025 with 65% year-over-year revenue growth in Q4,” said Peter Colis, CEO and Co-Founder of Ethos. “Our financial results demonstrate not only exceptional topline growth but also continued evidence of Ethos’ significant earnings potential. We are on a mission to protect families by democratizing access to life insurance, and reaching the milestone of 500,000 policies activated is a testament to that deep commitment.”

Fourth Quarter 2025 Financial Highlights

 

 

Revenue: Grew 65% year-over-year to $110.1 million

 

 

Direct Channel Revenue: Grew 93% year-over-year to $74.2 million

 

 

Third-Party Channel Revenue: Grew 27% year-over-year to $35.9 million

 

 

Net Income: $24.6 million, representing a 22% margin

 

 

Adjusted EBITDA: $25.8 million, representing a 23% margin

 

 

Gross Profit: $108.0 million, representing a 98% gross profit margin

 

 

Contribution Profit: $47.2 million, a 43% contribution profit margin

 

 

Net Income per Share: diluted, was $0.42 per share, a 163% improvement year-over-year, compared to $0.16 per share in the fourth quarter of 2024

 

 

Cash Flow: Net cash generated from operations was $4.9 million

Full Fiscal Year 2025 Financial Highlights

 

 

Revenue: Grew 52% year-over-year to $387.6 million

 

 

Direct Channel Revenue: Grew 40% year over year to $242.5 million

 

 

Third-Party Channel Revenue: Grew 79% year-over-year to $145.1 million

 

 

Net Income: $71.2 million, representing an 18% margin

 

 

Adjusted EBITDA: $89.0 million, representing a 23% margin

 

 

Gross Profit: $380.9 million, representing a 98% gross profit margin

 

 

Contribution Profit: $162.0 million, a 42% contribution profit margin

 

 

Net Income per Share: diluted, was $1.22 per share, a 44% improvement year-over-year, compared to $0.85 per share in the year ending December 31, 2024

 

 

Cash Flow: Net cash generated from operations was $36.2 million


 

Cash, cash equivalents, and investments: $157.4 million as of December 31, 2025

Recent Business Highlights

 

 

Families Protected: Activated 54,714 new policies in Q4 (42% growth), bringing the total lifetime policies to over 500,000

 

 

Agent Ecosystem Expansion: Ended 2025 with over 15,000 agents selling on the platform

 

 

Product Innovation: Launched two new products in Q4—Accumulation Indexed Universal Life with North American Sammons and Cancer Insurance with Aflac.

 

 

Carrier Network: Ended the quarter with six carriers

Financial Outlook

For the first quarter of 2026, Ethos expects the following:

 

 

Total Revenue: Between $144.0 million and $146.0 million, representing a 53% increase year-over-year at the midpoint

 

 

Adjusted EBITDA: Between $30.0 million and $32.0 million

For the full fiscal year 2026, Ethos expects the following:

 

 

Total Revenue: Between $510.0 million and $514.0 million, representing a 32% increase year-over-year at the midpoint

 

 

Adjusted EBITDA: Between $99.0 million and $103.0 million

Ethos’ financial outlook for the first quarter and full fiscal year 2026 are forward-looking, and actual results may differ materially as a result of many factors. Refer to the Forward-Looking Statements safe harbor below for information on the factors that could cause the company’s actual results to differ materially from these forward-looking statements.

Reconciliation of Adjusted EBITDA on a forward-looking basis to net income, the most directly comparable GAAP measure, is not available without unreasonable efforts due to high variability and complexity and low visibility with respect to certain charges excluded from this non-GAAP measure, including interest expense and interest income and income tax expenses. Ethos expects the variability of these items could have a significant, and potentially unpredictable, impact on its future GAAP financial results.

Conference Call Information

Ethos will host a conference call for analysts and investors to discuss its earnings results for the fourth quarter and fiscal year 2025 and outlook for its fiscal first quarter and fiscal year 2026 today at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). A live webcast and accompanying presentation can be accessed through the events section of the Ethos investor relations website at investors.ethos.com. A recorded webcast of the event will also be available on the Ethos Investor Relations website.


Non-GAAP Financial Information

Ethos has provided in this press release financial information that has not been prepared in accordance with generally accepted accounting principles in the United States (GAAP). We believe that non-GAAP financial measures, among others, provide important supplemental information to management and investors, help evaluate our business, identify trends affecting our performance, formulate business plans, and make strategic decisions.

The presentation of these non-GAAP financial measures is not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with GAAP. For further information regarding these non-GAAP measures, including the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, please refer to the financial tables below.

Adjusted EBITDA— Ethos defines Adjusted EBITDA as net income excluding interest expense, interest income, income tax expense, depreciation and amortization, and stock-based compensation expense as set forth in the table below. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA for a period by revenue for the same period. Ethos uses Adjusted EBITDA and Adjusted EBITDA Margin to assess performance, to inform the preparation of its annual operating budget and quarterly forecasts, to evaluate the effectiveness of its business strategies, and to assist its board of directors in monitoring its business and financial performance. Ethos believes that Adjusted EBITDA and Adjusted EBITDA Margin provide useful information to investors about its business and financial performance, enhance their overall understanding of its past performance and future prospects, including by providing consistency and comparability with its past financial performance, and allow for greater transparency with respect to measures used by its management in investors’ financial and operational decision making. In addition, Ethos believes Adjusted EBITDA is widely used by investors, securities analysts, and other parties in evaluating companies in its industry as a measure of operational performance.

Contribution Profit - Ethos defines Contribution Profit as profit less sales and marketing expense, which includes agent payments and underwriting costs for non-activated policies, plus stock-based compensation related to its employees and overhead costs allocated to sales and marketing expenses. Gross profit is defined as revenue less cost of revenue. Cost of revenue primarily consists of underwriting costs associated with activated policies. Overhead costs allocated to sales and marketing expenses include professional fees, technology expenses, and other related costs. Contribution Margin is calculated by dividing Contribution Profit for a period by revenue for the same period.

Non-GAAP Net Income and Non-GAAP Net Income Per Share, Basic and DilutedEthos defines non-GAAP net income as net income, adjusted to exclude stock-based compensation-related charges, in order to provide investors and management with greater visibility to the underlying performance of its recurring core business operations. Ethos defines non-GAAP net income per share, basic, as non-GAAP net income divided by the weighted-average shares outstanding. Ethos defines non-GAAP net income per share, diluted, as non-GAAP net income divided by the weighted-average shares outstanding, which includes the dilutive effect of potentially diluted common stock equivalents outstanding during the period, if any.


About Ethos

Ethos is a leading life insurance technology company on a mission to protect families by democratizing access to life insurance and empowering agents at scale. With its robust three-sided technology platform, Ethos is transforming the life insurance experience for consumers, agents, and carriers alike. Ethos offers instant, accessible products and a seamless online process that requires no medical exams and just a few health questions; it eliminates traditional barriers, making it easier than ever for everyone to protect their families. Ethos is redefining how life insurance is bought, sold, and underwritten.

Learn more at ethos.com.

Investor Relations Contact:

Aaron Turner

ir@ethos.com

Press Contact:

Allyson Savage

press@ethos.com

Forward-Looking Statements

This press release and the related conference call contain express and implied “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Ethos’ financial outlook for the fiscal quarter ending March 31, 2026 and the fiscal year ending December 31, 2026, the size of Ethos’ market opportunity, market trends, and Ethos’ business and financial strategy and plans. In some cases, you can identify forward-looking statements by terms such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “project,” “will,” or similar expressions. Such statements are subject to risks, uncertainties and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements. These include, but are not limited to: Ethos’ limited operating history at its current scale, scope and complexity; the growth rate of the markets in which Ethos competes; Ethos’ ability to effectively manage and sustain its growth; Ethos’s ability to compete with existing competitors and new market entrants; Ethos’ ability to attract new and retain existing carriers and agency counterparties; adoption of and engagement with Ethos’ platform by individual agents; Ethos’ brand awareness and the success of its marketing efforts to grow its business; potential damage to Ethos’ reputation; disruptions or other business interruptions that affect the availability of Ethos’ platform. Additional risks and uncertainties that could cause actual outcomes and results to differ materially from those contemplated by the forward-looking statements contained herein are included in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Ethos’ prospectus dated January 28, 2026 filed with the Securities and Exchange Commission (SEC) pursuant to Rule 424(b) of the Securities Act of 1933, as amended, on January 30, 2026, as they may be updated by Ethos’ subsequent filings with the SEC. Except as required by law, Ethos undertakes no obligation, and does not intend, to update these forward-looking statements.


ETHOS TECHNOLOGIES INC.

Condensed Consolidated Statements of Operations

(In Thousands, Except Per Share Data) (Unaudited)

 

     Three months Ended
December 31,
    Year Ended
December 31,
 
     2024     2025     2024     2025  

Revenue:

        

Commission

   $ 66,524     $ 110,077     $ 254,926     $ 387,608  

Total revenue

     66,524       110,077       254,926       387,608  

Costs and expenses:

        

Sales and marketing

     40,086       64,113       148,664       229,318  

General and administrative

     4,743       9,233       22,417       39,647  

Technology (exclusive of amortization)

     6,366       8,918       23,133       33,629  

Cost of revenue

     1,558       2,059       6,527       6,733  

Depreciation and amortization

     1,269       1,284       5,438       5,359  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total costs and expenses

     54,022       85,607       206,179       314,686  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income from operations

     12,502       24,470       48,747       72,922  

Other income (expense):

        

Interest expense

     (138     (765     (595     (3,170

Interest income

     1,322       1,359       5,599       5,831  

Other income, net

     24       61       185       161  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total other income, net

     1,208       655       5,189       2,822  

Net income before provision for income taxes

     13,710       25,125       53,936       75,744  

Income tax expense

     (4,162     (564     (5,104     (4,593
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

     9,548       24,561       48,832       71,151  
  

 

 

   

 

 

   

 

 

   

 

 

 

Per share data:

        

Basic net income per share

   $ 0.60     $ 1.48     $ 3.05     $ 4.31  

Diluted net income per share

   $ 0.16     $ 0.42     $ 0.85     $ 1.22  

Shares used in computing basic net income per share

     16,031       16,600       16,007       16,490  

Shares used in computing diluted net income per share

     58,484       57,886       57,600       58,416  


ETHOS TECHNOLOGIES INC.

Condensed Consolidated Balance Sheets

(In Thousands, Except Per Share Data)(Unaudited)

 

     As of December 31,  
     2024     2025  

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 35,075     $ 91,091  

Short-term investments

     68,279       34,876  

Accounts receivable, net

     30,303       36,498  

Commissions receivable-current, net

     15,079       28,786  

Prepaid and other assets

     26,070       54,553  
  

 

 

   

 

 

 

Total current assets

     174,806       245,804  

Long-term assets:

    

Commissions receivable, net

     173,096       224,219  

Property and equipment, net

     7,424       8,189  

Operating lease right-of-use assets

     2,536       2,183  

Goodwill

     2,238       2,238  

Acquired intangible assets, net of amortization

     221       662  

Long-term investments

     35,002       31,468  

Other long-term assets

     558       574  
  

 

 

   

 

 

 

Total long-term assets

     221,075       269,533  
  

 

 

   

 

 

 

Total assets

   $ 395,881     $ 515,337  
  

 

 

   

 

 

 

Liabilities, redeemable preferred stock and stockholders’ deficit

    

Current liabilities:

    

Accounts payable

   $ 24,303     $ 55,070  

Accrued expenses

     19,217       39,224  

Liabilities related to sale of commissions receivable-current

     9,382       11,750  

Operating lease liabilities-current

     753       1,125  

Other current liabilities

     13,945       6,021  
  

 

 

   

 

 

 

Total current liabilities

     67,600       113,190  

Long-term liabilities:

    

Liabilities related to sale of commissions receivable-non-current

     24,163       12,509  

Operating lease liabilities-non-current

     1,864       1,228  

Deferred tax liability

     3,907       8,529  

Other long-term liabilities

     1,500        
  

 

 

   

 

 

 

Total long-term liabilities

     31,434       22,266  
  

 

 

   

 

 

 

Total liabilities

     99,034       135,456  

Commitments and contingencies

    

Redeemable convertible preferred stock, par value $0.0001

     403,997       403,997  

Stockholders’ deficit:

    

Common stock, $0.0001 par value

     2       2  

Additional paid-in capital

     66,991       78,950  

Accumulated other comprehensive loss

     (478     (554

Accumulated deficit

     (173,665     (102,514
  

 

 

   

 

 

 

Total stockholders’ deficit

     (107,150     (24,116
  

 

 

   

 

 

 

Total liabilities, redeemable convertible preferred stock and stockholders’ deficit

   $ 395,881     $ 515,337  
  

 

 

   

 

 

 


ETHOS TECHNOLOGIES INC.

Condensed Consolidated Statements of Cash Flows

(In Thousands)(Unaudited)

 

     Year Ended
December 31,
 
     2024     2025  

Cash flows from operating activities

    

Net income

   $ 48,832     $ 71,151  

Adjustments to reconcile net income to net cash provided by (used in) operating activities:

    

Deferred taxes

     3,907       4,622  

Depreciation and amortization

     5,438       5,359  

Non-cash interest expense

     595       3,170  

Accretion of discounts and premium, investments

     (3,133     (1,211

Stock-based compensation

     3,166       10,596  

Operating lease right-of-use asset amortization

     42       903  

Unrealized gain foreign currency translation

     (199     (303

Changes in operating assets and liabilities:

    

Prepaid and other assets

     (23,902     (21,334

Other long-term assets

     (378     (16

Accounts payable

     12,691       30,631  

Accounts receivable

     (13,626     (11,195

Commissions receivable

     (9,166     (13,707

Long-term commissions receivable

     (53,851     (51,123

Accrued expenses

     7,298       18,920  

Other current liabilities

     12,378       (8,738

Other long-term liabilities

     (1,000     (1,500
  

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     (10,908     36,225  

Cash flows from investing activities

    

Purchase of property and equipment

     (776     (1,491

Purchase of domain name

     (250     (500

Purchase of investments

     (154,675     (66,709

Proceeds from maturity of investments

     145,003       99,870  

Sales of investments

     13,360       4,983  

Investment in software development costs

     (3,558     (4,286
  

 

 

   

 

 

 

Net cash provided by (used in) investing activities

     (896     31,867  

Cash flows from financing activities

    

Proceeds from liabilities related to sale of commissions receivable

     23,550       5,000  

Repayment of liabilities related to sale of commissions receivable

     (1,902     (11,952

Proceeds from exercise of stock options and warrants

     209       1,058  

Payment of deferred offering costs

     —        (6,155
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     21,857       (12,049

Net increase in cash and cash equivalents

     10,053       56,043  

Effect of exchange rates on cash

     2       (27

Cash and cash equivalents, beginning of period

     25,020       35,075  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 35,075     $ 91,091  
  

 

 

   

 

 

 


ETHOS TECHNOLOGIES INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(In Thousands) (Unaudited)

 

     Three Months Ended
December 31,
    Year Ended
December 31,
 
     2024     2025     2024     2025  

Gross Profit

   $ 64,966     $ 108,018     $ 248,399     $ 380,875  

Less: Sales and Marketing

     (40,086     (64,113     (148,664     (229,318

Add: Stock-based Compensation Allocated to Sales and Marketing

     297       4       687       2,047  

Add: Professional Fees Allocated to Sales and Marketing

     394       1,631       831       2,805  

Add: Technology Expenses Allocated to Sales and Marketing

     509       880       1,931       3,077  

Add: Other Expenses Allocated to Sales and Marketing

     406       803       1,393       2,549  
  

 

 

   

 

 

   

 

 

   

 

 

 

Contribution Profit

   $ 26,486     $ 47,223     $ 104,577     $ 162,035  
  

 

 

   

 

 

   

 

 

   

 

 

 

Contribution Profit Margin

     40     43     41     42

 

     Three Months Ended
December 31,
    Year Ended
December 31,
 
     2024     2025     2024     2025  

Net Income Before Provision for Income Tax

   $ 13,710     $ 25,125     $ 53,936     $ 75,744  

Interest Income

     (1,322     (1,359     (5,599     (5,831

Interest Expense

     138       765       595       3,170  

Depreciation and Amortization

     1,269       1,284       5,438       5,359  

Stock-based Compensation

     897       32       3,166       10,596  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 14,692     $ 25,847     $ 57,536     $ 89,038  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA Margin

     22     23     23     23

 

     Three Months Ended
December 31,
     Year Ended
December 31,
 
     2024      2025      2024      2025  

GAAP Net Income

   $ 9,548      $ 24,561      $ 48,832      $ 71,151  

Stock-based Compensation

     897        32        3,166        10,596  
  

 

 

    

 

 

    

 

 

    

 

 

 

Non-GAAP net income

   $ 10,445      $ 24,593      $ 51,998      $ 81,747  

Per Share Data:

           

Weighted average shares used in computing net income per share, basic

     16,031        16,600        16,007        16,490  

Weighted average shares used in computing net income per share, diluted

     58,484        57,886        57,600        58,416  

GAAP net income per share attributable to common stockholders, basic

   $ 0.60      $ 1.48      $ 3.05      $ 4.31  

GAAP net income per share attributable to common stockholders, diluted

   $ 0.16      $ 0.42      $ 0.85      $ 1.22  

Non-GAAP net income per share attributable to common stockholders, basic

   $ 0.65      $ 1.48      $ 3.25      $ 4.96  

Non-GAAP net income per share attributable to common stockholders, diluted

   $ 0.18      $ 0.42      $ 0.90      $ 1.40  

FAQ

How did Ethos Technologies Inc. (LIFE) perform in Q4 2025?

Ethos delivered strong Q4 2025 results, with revenue of $110,077 thousand, up from $66,524 thousand. The company highlighted 65% year-over-year revenue growth, and net income increased to $24,561 thousand, showing meaningful operating leverage as the business scaled.

What were Ethos Technologies Inc. (LIFE) full-year 2025 financial results?

For 2025, Ethos reported revenue of $387,608 thousand, up from $254,926 thousand. Net income rose to $71,151 thousand from $48,832 thousand. These results reflect rapid growth alongside improved profitability across the company’s life insurance technology platform.

How profitable was Ethos Technologies Inc. (LIFE) on a non-GAAP basis in 2025?

Ethos reported 2025 Adjusted EBITDA of $89,038 thousand with an Adjusted EBITDA Margin of 23%. Contribution Profit reached $162,035 thousand with a Contribution Margin of 42%, underscoring attractive underlying economics after sales, marketing and allocated overhead adjustments.

What earnings per share did Ethos Technologies Inc. (LIFE) generate in 2025?

In 2025, Ethos posted GAAP diluted net income per share of $1.22 and basic net income per share of $4.31. On a non-GAAP basis, diluted net income per share was $1.40, while basic non-GAAP net income per share reached $4.96.

How did Ethos Technologies Inc. (LIFE) end 2025 from a balance sheet perspective?

As of December 31, 2025, Ethos held $91,091 thousand in cash and cash equivalents and total assets of $515,337 thousand. Total liabilities were $135,456 thousand, and the accumulated deficit narrowed to $102,514 thousand, improving the overall stockholders’ deficit position.

What key business milestones did Ethos Technologies Inc. (LIFE) highlight for 2025?

Ethos emphasized reaching 500,000 activated policies, supporting its mission to democratize access to life insurance. Management also pointed to strong Q4 momentum and the company’s three-sided technology platform as drivers of growth across consumers, agents, and carriers.

Filing Exhibits & Attachments

4 documents
Ethos Technologies Corp.

NASDAQ:LIFE

LIFE Rankings

LIFE Latest News

LIFE Latest SEC Filings

LIFE Stock Data

771.32M
10.14M
Biological Product (except Diagnostic) Manufacturing
Biological Products, (no Disgnostic Substances)
Link
US
SAN DIEGO